Emerging Disparities in Prevention and Survival Outcomes for Patients with Head and Neck Cancer and Recommendations for Health Equity

被引:5
作者
Salinas, Manisha [1 ]
Chintakuntlawar, Ashish [2 ]
Arasomwan, Ivie [3 ]
Eltahir, Ahmed [3 ]
Price, Katharine A. R. [2 ]
机构
[1] Mayo Clin, Dept Hematol & Oncol, 4500 San Pablo Rd S, Jacksonville, FL 32224 USA
[2] Mayo Clin, Dept Hematol & Oncol, 200 First St SW, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Otolaryngol Head & Neck Surg, Rochester, MN USA
关键词
Cancer disparities; Head and neck cancer; Health equity; Rurality; Nutrition; Telehealth; Digital health; HPV vaccination; SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; DIETARY PATTERNS; LARYNGEAL-CANCER; HPV VACCINATION; ORAL-CANCER; VITAMIN-D; RISK; URBAN; PHARYNGEAL;
D O I
10.1007/s11912-022-01273-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose of Review The aim of this review is to describe less known and emerging disparities found in the prevention and survival outcomes for patients with head and neck cancer (HNC) that are likely to play an increasingly important role in HNC outcomes and health inequities. Recent Findings The following factors contribute to HNC incidence and outcomes: (1) the effect of rurality on prevention and treatment of HNC, (2) dietary behavior and nutritional factors influencing the development of and survival from HNC, and (3) barriers and benefits of telehealth for patients with HNC. Rurality, nutrition and diet, and telehealth usage and access are significant contributors to the existing health disparities associated with HNC. Population and culturally specific interventions are urgently needed as well as more research to further define the issues and develop appropriate population and individual level solutions.
引用
收藏
页码:1153 / 1161
页数:9
相关论文
共 50 条
  • [31] Transfusion as a Predictor of Recurrence and Survival in Head and Neck Cancer Surgery Patients
    Chau, Jason K. M.
    Harris, Jeffery R.
    Seikaly, Hadi R.
    JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2010, 39 (05): : 516 - 522
  • [32] Neighborhood deprivation and clinical outcomes among head and neck cancer patients
    Reitzel, Lorraine R.
    Nga Nguyen
    Zafereo, Mark E.
    Li, Guojun
    Wei, Qingyi
    Sturgis, Erich M.
    HEALTH & PLACE, 2012, 18 (04) : 861 - 868
  • [33] A population-based study of therapy and survival for patients with head and neck cancer treated in the community
    Ullmann, Claudio Dansky
    Harlan, Linda C.
    Shavers, Vickie L.
    Stevens, Jennifer L.
    CANCER, 2012, 118 (18) : 4452 - 4461
  • [34] Baseline Health Perceptions, Dysphagia, and Survival in Patients With Head and Neck Cancer
    Lango, Miriam N.
    Egleston, Brian
    Fang, Carolyn
    Burtness, Barbara
    Galloway, Thomas
    Liu, Jeffrey
    Mehra, Ranee
    Ebersole, Barbara
    Moran, Kathleen
    Ridge, John A.
    CANCER, 2014, 120 (06) : 840 - 847
  • [35] Oral health and risk for head and neck squamous cell carcinoma: the Carolina Head and Neck Cancer Study
    Divaris, Kimon
    Olshan, Andrew F.
    Smith, Joanna
    Bell, Mary E.
    Weissler, Mark C.
    Funkhouser, William K.
    Bradshaw, Patrick T.
    CANCER CAUSES & CONTROL, 2010, 21 (04) : 567 - 575
  • [36] Survival outcomes for head and neck cancer patients with N3 cervical nodal metastases
    Virk, Jagdeep S.
    Ingle, Manasi
    Podesta, Christine M.
    Gujral, Dorothy M.
    Awad, Zaid
    CLINICAL OTOLARYNGOLOGY, 2020, 45 (03) : 342 - 349
  • [37] Impact of obesity on outcomes for patients with head and neck cancer
    Hicks, Daniel F.
    Bakst, Richard
    Doucette, John
    Kann, Benjamin H.
    Miles, Brett
    Genden, Eric
    Misiukiewicz, Krzysztof
    Posner, Marshall
    Gupta, Vishal
    ORAL ONCOLOGY, 2018, 83 : 11 - 17
  • [38] Emerging tyrosine kinase inhibitors for head and neck cancer
    Bossi, Paolo
    Locati, Laura
    Licitra, Lisa
    EXPERT OPINION ON EMERGING DRUGS, 2013, 18 (04) : 445 - 459
  • [39] Explaining Racial Disparities in Surgically Treated Head and Neck Cancer
    Jassal, Japnam S.
    Cramer, John D.
    LARYNGOSCOPE, 2021, 131 (05) : 1053 - 1059
  • [40] Emerging drugs for head and neck cancer
    Wen, Yihui
    Grandis, Jennifer R.
    EXPERT OPINION ON EMERGING DRUGS, 2015, 20 (02) : 313 - 329